Skip to main content
SpringerLink
Log in

Introduction

  • Chapter
  • First Online:
PET/CT in Radiotherapy Planning

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 954 Accesses

Abstract

Worldwide, cancer is a major public health issue and accurate diagnosis, staging and follow-up is essential for optimal management. PET-CT imaging has a significant role in the staging of disease and assessment of treatment response.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cancer Research UK. What radiotherapy is. 2014. http://www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/radiotherapy/about/what-radiotherapy-is. Accessed 9 Jan 2015.

  2. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S–50S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Berthelsen AK, Dobbs J, Kjellen E, et al. What’s new in target volume definition for radiologists in ICRU report 71? How can the ICRU volume definitions be integrated in clinical practice? Cancer Imaging. 2007;7:104–16.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ben-Haim S, Ell P. 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. J Nucl Med. 2009;50(1):88–99.

    Article  PubMed  Google Scholar 

  5. Nestle U, Walter K, Schmidt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys. 1999;44(3):593–7.

    Article  CAS  PubMed  Google Scholar 

  6. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22(21):4357–68.

    Article  PubMed  Google Scholar 

  7. Bentzen SM, Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol. 2011;21(2):101–10.

    Article  PubMed  PubMed Central  Google Scholar 

  8. McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev. 2008;27(4):555–73.

    Article  PubMed  Google Scholar 

  9. Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Nucl Med Biol. 1998;25(4):317–22.

    Article  CAS  PubMed  Google Scholar 

  10. Reshef A, Shirvan A, Akselrod-Ballin A, Wall A, Ziv I. Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med. 2010;51(6):837–40.

    Article  CAS  PubMed  Google Scholar 

  11. Oborski MJ, Laymon CM, Lieberman FS, Drappatz J, Hamilton RL, Mountz JM. First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy. Brain Behav. 2014;4(2):312–5.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Tehrani OS, Shields AF. PET imaging of proliferation with pyrimidines. J Nucl Med. 2013;54(6):903–12.

    Article  CAS  PubMed  Google Scholar 

  13. Haubner R. PET radiopharmaceuticals in radiation treatment planning—synthesis and biological characteristics. Radiother Oncol. 2010;96(3):280–7.

    Article  PubMed  Google Scholar 

  14. Grassi I, Nanni C, Allegri V, et al. The clinical use of PET with (11)C-acetate. Am J Nucl Med Mol Imaging. 2012;2(1):33–47.

    CAS  PubMed  Google Scholar 

  15. Virgolini I, Ambrosini V, Bomanji JB, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37(10):2004–10.

    Google Scholar 

  16. Giraud P, Elles S, Helfre S, et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol. 2002;62(1):27–36.

    Article  PubMed  Google Scholar 

  17. Foster B, Bagci U, Mansoor A, Xu Z, Mollura DJ. A review on segmentation of positron emission tomography images. Comput Biol Med. 2014;50:76–96.

    Article  PubMed  Google Scholar 

  18. Cheebsumon P, Boellaard R, de Ruysscher D, et al. Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology. Eur J Nucl Med Mol Imaging. 2012;2(1):56.

    Google Scholar 

  19. Frings V, Van Velden FH, Velasquez LM, et al. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273(2):539–48.

    Article  PubMed  Google Scholar 

  20. Thorwarth D, Leibfarth S, Monnich D. Potential role of PET/MRI in radiotherapy planning. Clin Transl Imaging. 2013;1:45–51.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology & Radionuclide Radiology, The Royal Marsden NHS Foundation Trust, London, UK

    Lucy Fowkes

  2. Head & Neck and Thyroid Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK

    Kate Newbold

  3. Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK

    Kate Newbold

Authors
  1. Lucy Fowkes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kate Newbold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kate Newbold .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine and PET, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

    Sue Chua

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fowkes, L., Newbold, K. (2017). Introduction. In: Chua, S. (eds) PET/CT in Radiotherapy Planning . Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-54744-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54744-2_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54743-5

  • Online ISBN: 978-3-319-54744-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation